Skip to main content
. 2014 May 29;12:169. doi: 10.1186/1477-7819-12-169

Table 1.

Summary data of the original studies

Author Country Year Type of study Patients Control Cut off (pmol/L) TP FP FN TN SEN SPE
Moore RG et al. [5]
USA
2008
prospective/retrospective
171
156
/
78
8
93
148
46
95
Zanotti L et al. [6]
Italy
2012
retrospective
193(152 + 41)
125
51
152
19
41
106
79
85
 
 
 
 
 
 
64
127
6
66
119
66
95
Angioli R et al. [7]
Italy
2013
prospective
101(95 + 6)
103
70
60
0
41
103
59
100
 
 
 
 
 
 
150
36
0
65
103
36
100
Omer Bet al. [8]
Turkey
2013
prospective l
64(54 + 10)
94(60 + 34)
60
48
32
16
62
75
66
Bignotti E et al. [9]
Italy
2011
prospective
138(109 + 29)
76
/
92
4
46
72
67
95
Zhang, Ai-min et al. [10]
China
2012
prospective
124
206(97 + 109)
/
51
10
73
196
41
95
Total       791 760              

Studies [6], [7], [8] and [9] included patients with different pathological types. The pathological types of patients in study [5] and study [10] are unclear. Studies [8] and [10] included people with uterine benign disease and had healthy people as controls. The controls of other studies are healthy.

FN, False Negative; FP, False Positive; SEN, Sensitivity; SPE, Specificity TN, True Negative; TP, True Positive.